Hypo-RESOLVE consortium. Glycaemic thresholds for counterregulatory hormone and symptom responses to hypoglycaemia in people with and without type 1 diabetes: a systematic review.
View / Open Files
Authors
Verhulst, Clementine
Fabricius, Therese
Teerenstra, Steven
Kristensen, Peter
Tack, Cees
McCrimmon, Rory
Heller, Simon
Amiel, Stephanie
Pedersen-Bjergaard, Ulrik
de Galan, Baastian
Journal Title
Diabetologia
ISSN
0012-186X
Publisher
Springer
Type
Article
This Version
AM
Metadata
Show full item recordCitation
Evans, M., Verhulst, C., Fabricius, T., Teerenstra, S., Kristensen, P., Tack, C., McCrimmon, R., et al. Hypo-RESOLVE consortium. Glycaemic thresholds for counterregulatory hormone and symptom responses to hypoglycaemia in people with and without type 1 diabetes: a systematic review.. Diabetologia https://doi.org/10.17863/CAM.84372
Abstract
Aim/hypothesis: The physiological counterregulatory response to hypoglycaemia is reportedly hierarchically organized, with hormone responses usually preceding symptomatic awareness and autonomic responses preceding neuroglycopenic responses. To more accurately compare thresholds for activation of these responses between people with or without type 1 diabetes, we performed a systematic review on stepped hyperinsulinaemic-hypoglycaemic glucose clamps.
Methods: A literature search in PubMed and EMBASE was conducted. We included articles published between 1980 and 2018 involving hyperinsulinaemic stepped hypoglycaemic glucose clamps among people with or without type 1 diabetes. Glycaemic thresholds for counterregulatory hormone and/or symptom responses to hypoglycaemia were estimated and compared using methods for interval censored data, where the intervals were either extracted directly or calculated from the data provided by the study. A glycaemic threshold was defined as the glucose level at which the response exceeded the 95% confidence interval of the mean baseline measurement or euglycaemic control clamp.
Results: A total of 63 articles were included. Compared to non-diabetic controls, in people with type 1 diabetes, the median (IQR) glycaemic thresholds for adrenaline (3.8 (3.2-4.2) vs. 3.4 (2.8-3.9 mmol/l), noradrenaline (3.2 (3.2-3.7) vs. 3.0 (2.8-3.1) mmol/l), cortisol (3.5 (3.2-4.2) mmol/l vs. 2.8 (2.8-3.4) mmol/l), and growth hormone (3.8 (3.3-3.8) vs. 3.2 (3.0-3.3) mmol/l) all occurred at lower glucose levels in people with than in those without diabetes (all p ≤ 0.01). Similarly, although both autonomic (3.4 (3.4-3.4) vs. 3.0 (2.8-3.4) mmol/l) and neuroglycopenic (3.4 (2.8-∞ vs. 3.0 (3.0-3.1) mmol/l) symptom responses were elicited at lower glucose levels in people with type 1 diabetes, the thresholds for autonomic and neuroglycopenic symptoms did not differ for each individual subgroup.
Conclusions/interpretation: People with type 1 diabetes have glycaemic thresholds for counterregulatory hormone and symptom responses at lower glucose levels than people without diabetes. Autonomic and neuroglycopenic symptoms responses are generated at about similar levels of hypoglycaemia.
Sponsorship
This article has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 777460. The JU receives support from the European Union's Horizon 2020 research and innovation program and EFPIA and T1D Exchange, JDRF, International Diabetes Federation (IDF), The Leona M. and Harry B. Helmsley Charitable Trust.
Embargo Lift Date
2025-05-09
Identifiers
This record's DOI: https://doi.org/10.17863/CAM.84372
This record's URL: https://www.repository.cam.ac.uk/handle/1810/336949
Statistics
Total file downloads (since January 2020). For more information on metrics see the
IRUS guide.
Recommended or similar items
The current recommendation prototype on the Apollo Repository will be turned off on 03 February 2023. Although the pilot has been fruitful for both parties, the service provider IKVA is focusing on horizon scanning products and so the recommender service can no longer be supported. We recognise the importance of recommender services in supporting research discovery and are evaluating offerings from other service providers. If you would like to offer feedback on this decision please contact us on: support@repository.cam.ac.uk